Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manisha Prajapat

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Indian Journal of Pharmacology|March 28, 2022
Update on omicron variant: What we know so farGajendra Choudhary, Manisha Prajapat, J Kumaravel, et al.
Dermatologic Therapy|November 13, 2019
Therapeutic options for management of Hori's nevus: A systematic reviewHarpinder Kaur, Phulen Sarma, Sukhmandeep Kaur, et al.
Computers in Biology and Medicine|May 22, 2021
Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTDArushi Chauhan, Pramod Avti, Nishant Shekhar, et al.
ACS Chemical Neuroscience|September 27, 2022
Granulocyte Colony-Stimulating Factor Improved Core Symptoms of Autism Spectrum Disorder via Modulating Glutamatergic Receptors in the Prefrontal Cortex and Hippocampus of Rat BrainsAbhishek Mishra, Rubal Singla, Rohit Kumar, et al.
Journal of Molecular Graphics & Modelling|September 1, 2020
Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2Manisha Prajapat, Nishant Shekhar, Phulen Sarma, et al.
Journal of Biomolecular Structure & Dynamics|May 17, 2021
Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findingsPramod Avti, Arushi Chauhan, Nishant Shekhar, et al.
Fundamental & Clinical Pharmacology|March 30, 2021
Everolimus: A potential therapeutic agent targeting PI3K/Akt pathway in brain insulin system dysfunction and associated neurobehavioral deficitsSeema Bansal, Madhunika Agrawal, Saniya Mahendiratta, et al.
Indian Journal of Pharmacology|March 24, 2020
Drug targets for corona virus: A systematic reviewManisha Prajapat, Phulen Sarma, Nishant Shekhar, et al.
Indian Journal of Pharmacology|June 23, 2020
Update on the target structures of SARS-CoV-2: A systematic reviewManisha Prajapat, Phulen Sarma, Nishant Shekhar, et al.
Journal of Biomolecular Structure & Dynamics|April 9, 2020
In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)Phulen Sarma, Nishant Shekhar, Manisha Prajapat, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Indian Journal of Pharmacology|March 28, 2022
Update on omicron variant: What we know so farGajendra Choudhary, Manisha Prajapat, J Kumaravel, et al.
Dermatologic Therapy|November 13, 2019
Therapeutic options for management of Hori's nevus: A systematic reviewHarpinder Kaur, Phulen Sarma, Sukhmandeep Kaur, et al.
Computers in Biology and Medicine|May 22, 2021
Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTDArushi Chauhan, Pramod Avti, Nishant Shekhar, et al.
ACS Chemical Neuroscience|September 27, 2022
Granulocyte Colony-Stimulating Factor Improved Core Symptoms of Autism Spectrum Disorder via Modulating Glutamatergic Receptors in the Prefrontal Cortex and Hippocampus of Rat BrainsAbhishek Mishra, Rubal Singla, Rohit Kumar, et al.
Journal of Molecular Graphics & Modelling|September 1, 2020
Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2Manisha Prajapat, Nishant Shekhar, Phulen Sarma, et al.
Journal of Biomolecular Structure & Dynamics|May 17, 2021
Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findingsPramod Avti, Arushi Chauhan, Nishant Shekhar, et al.
Fundamental & Clinical Pharmacology|March 30, 2021
Everolimus: A potential therapeutic agent targeting PI3K/Akt pathway in brain insulin system dysfunction and associated neurobehavioral deficitsSeema Bansal, Madhunika Agrawal, Saniya Mahendiratta, et al.
Indian Journal of Pharmacology|March 24, 2020
Drug targets for corona virus: A systematic reviewManisha Prajapat, Phulen Sarma, Nishant Shekhar, et al.
Indian Journal of Pharmacology|June 23, 2020
Update on the target structures of SARS-CoV-2: A systematic reviewManisha Prajapat, Phulen Sarma, Nishant Shekhar, et al.
Journal of Biomolecular Structure & Dynamics|April 9, 2020
In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)Phulen Sarma, Nishant Shekhar, Manisha Prajapat, et al.
Pageof 5